
11 - 50 employees
Founded 2016
🧬 Biotechnology
⚕️ Healthcare Insurance
💊 Pharmaceuticals
Biotechnology • Healthcare Insurance • Pharmaceuticals
Orum Therapeutics is a clinical-stage biotechnology company that pioneers a novel class of antibody-drug conjugates (ADCs). The company develops innovative therapies that combine the efficacy of protein degraders with the precision of antibodies to change the landscape of disease treatment. Through its advanced TPD² cell-selective degradation technology, Orum aims to improve the efficacy, safety, and pharmacokinetics of targeted therapies.
🕒 February 12
External Research Leader overseeing the Degrader-Antibody Conjugate pipeline for Orum Therapeutics. Managing CRO relationships and driving IND-enabling studies across complex therapeutic modalities in China.
🗣️🇨🇳 Chinese Required